The stock closed at ₹626.45, down 0.63% from the previous close of ₹630.45, with intraday prices ranging between ₹623.55 and ₹631.00. Over the past 52 weeks, Rossari Biotech’s price has fluctuated between a low of ₹568.05 and a high of ₹883.00, highlighting significant volatility within the year. When compared to the Sensex, which has shown positive returns over multiple periods, Rossari Biotech’s returns have been subdued. For instance, the stock’s one-month return stands at -6.61%, contrasting with the Sensex’s 0.86% gain. Year-to-date, the stock has recorded a decline of 20.47%, while the Sensex has advanced by 8.36%.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- Recently turned profitable
- Strong business fundamentals
- Pre-breakout opportunity
Examining technical indicators, the Moving Average Convergence Divergence (MACD) presents a nuanced picture: weekly data suggests a mildly bullish stance, whereas monthly readings indicate bearish momentum. The Relative Strength Index (RSI) shows no definitive signal on a weekly basis but reflects bullish tendencies monthly. Bollinger Bands, a volatility measure, signal bearish trends on both weekly and monthly charts. Daily moving averages align with a bearish outlook, reinforcing the recent downward momentum in price action.
Additional technical tools such as the Know Sure Thing (KST) indicator reveal mildly bullish signals weekly but bearish trends monthly. The Dow Theory analysis points to a mildly bearish weekly trend with no clear monthly direction. On-Balance Volume (OBV) data also suggests mildly bearish pressure weekly, with no discernible trend monthly. These mixed signals underscore the complexity of Rossari Biotech’s current technical evaluation and the need for investors to consider multiple timeframes when analysing momentum shifts.
Why settle for Rossari Biotech ? SwitchER evaluates this Specialty Chemicals small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- Comprehensive evaluation done
- Superior opportunities identified
- Smart switching enabled
From a market capitalisation perspective, Rossari Biotech holds a grade of 3, reflecting its mid-tier positioning within the Specialty Chemicals sector. The company’s Mojo Score currently stands at 44.0, with a recent adjustment in its evaluation grade from Hold to Sell as of 18 Nov 2025, triggered by technical parameter changes noted on 19 Nov 2025. This revision highlights the impact of technical momentum shifts on the stock’s overall assessment.
Longer-term returns for Rossari Biotech have lagged behind the Sensex benchmark. Over one year, the stock has recorded a return of -19.18%, while the Sensex has gained 9.48%. The three-year and five-year returns for the stock are -22.27% and -20.28% respectively, compared to Sensex returns of 37.31% and 91.65% over the same periods. This divergence emphasises the challenges faced by Rossari Biotech in matching broader market performance despite sectoral growth trends.
Investors analysing Rossari Biotech should weigh these technical signals alongside fundamental factors and sector dynamics. The mixed technical indicators suggest a period of consolidation or potential volatility ahead, with the stock’s price momentum currently skewed towards bearishness in several key measures. Monitoring the evolution of MACD, RSI, and moving averages will be critical in assessing any future shifts in trend direction.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
